NCT03165578

Brief Summary

The objective of the present study is to identify brain networks in patients that contribute to successfully learning self-regulation with real-time fMRI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

May 19, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 24, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

May 24, 2017

Status Verified

May 1, 2017

Enrollment Period

3.4 years

First QC Date

May 19, 2017

Last Update Submit

May 22, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • brain patterns that mediate learning self-regulation in patients with fMRI neurofeedback

    Functional MRI data will be analysed using a whole brain mixed effect analysis across all subjects that compares brain patterns during self-regulation and baseline.

    12 months

Secondary Outcomes (3)

  • neurofeedback learning success

    12 months

  • behavioral consequences of neurofeedback training

    12 months

  • maintenance of learned self-regulation

    12 months

Study Arms (2)

Neurofeedback

EXPERIMENTAL

Neurofeedback training.

Other: Neurofeedback training

Sham Feedback

SHAM COMPARATOR

Sham controlled neurofeedback training. Subjects in the sham control group will undergo the same procedure as subjects in the experimental group, but instead of being shown feedback derived from their own brain activity, they will be shown replayed feedback values from a randomly chosen subject of the experimental group.

Other: Sham Feedback

Interventions

In a neurofeedback setting, brain activity is measured non-invasively, the brain imaging data is analyzed in real-time, and then feedback regarding the current level of brain activity is provided to the subject.

Neurofeedback

Sham controlled neurofeedback training. Subjects in the sham control group will undergo the same procedure as subjects in the experimental group, but instead of being shown feedback derived from their own brain activity, they will be shown replayed feedback values from a randomly chosen subject of the experimental group.

Sham Feedback

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Magnetic resonance imaging compatibility.
  • DSM-V diagnosis of major depressive disorder, post-traumatic stress disorder, or nicotine addiction, respectively.

You may not qualify if:

  • Other physical or psychiatric disorders.
  • Current substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of Psychiatry, University of Zurich

Zurich, Canton of Zurich, 8032, Switzerland

RECRUITING

MeSH Terms

Conditions

Tobacco Use DisorderDepressionStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersBehavioral SymptomsBehaviorStress Disorders, TraumaticTrauma and Stressor Related Disorders

Study Officials

  • Frank Scharnowski, Prof. Dr.

    Hospital of Psychiatry, University of Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Frank Scharnowski, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

May 19, 2017

First Posted

May 24, 2017

Study Start

May 1, 2017

Primary Completion

September 30, 2020

Study Completion

September 30, 2020

Last Updated

May 24, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share

Locations